Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
about
DNA damage response markers are differentially expressed in BRCA-mutated breast cancersPrevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast CancersCurrent Status of Poly(ADP-ribose) Polymerase Inhibitors as Novel Therapeutic Agents for Triple-Negative Breast Cancer.Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients.Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers.Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib.Immunoprofile from tissue microarrays to stratify familial breast cancer patientsReview of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases.Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer.BRCA1/2-negative hereditary triple-negative breast cancers exhibit BRCAness.Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria
P2860
Q35131267-4447FC43-E068-4F6E-BF6C-D2B310AE2E7CQ35665705-FBD65B7A-1966-42F7-A446-F708065A0BD9Q35684568-92291978-65F6-48E9-948C-402225AA5135Q35919277-511C13A5-F55B-48CC-8148-4923454A3FC0Q36132338-FAE2652B-3C9D-4596-8B09-3FF141704A2AQ36195450-A0647952-B2D5-4EFA-860E-FCE20B0E0FD1Q36413928-CE137113-7E6C-46FD-A161-E52DDCB29260Q38191981-8FED9507-C287-4DB7-9965-F5CF21F34912Q41603225-004FA7C4-45EE-4157-AC9D-297BFEBA4A8EQ42490495-4E2DBFD6-17E1-4670-8407-836E691D9A9FQ48906011-38C9AE58-9B18-4E32-A4BE-63FFF833F384Q58695244-CFD9CBC1-B993-44CF-B13A-5E6D0CDC7223
P2860
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
@ast
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
@en
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
@nl
type
label
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
@ast
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
@en
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
@nl
prefLabel
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
@ast
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
@en
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
@nl
P2093
P2860
P1433
P1476
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
@en
P2093
Karol Gugala
Pawel Domagala
Tomasz Huzarski
Wenancjusz Domagala
P2860
P2888
P356
10.1007/S00428-010-0988-3
P50
P577
2010-10-13T00:00:00Z